Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 20/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 20/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 12/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL2484663 | 1.00 | CHRM2 (0.52) | CHRM2CHRM3CHRM1 | |
| SCHEMBL15144691 | 0.93 | CHRM3 (0.57) | CHRM2CHRM3CHRM1 | |
| SCHEMBL3775952 | 0.93 | CHRM3 (0.57) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL2486473 | 0.91 | CHRM3 (0.51) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL2995422 | 0.91 | CHRM3 (0.51) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL2487985 | 0.89 | CHRM3 (0.53) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL2990371 | 0.89 | CHRM3 (0.53) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL9984393 | 0.89 | CHRM3 (0.53) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL2485505 | 0.88 | CHRM3 (0.55) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL2989743 | 0.88 | CHRM3 (0.55) | CHRM2CHRM3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376489-B1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF | CHIESI FARMA SPA (IT) | 2015-04-22 | — | — | EP | claimed |
| US-8455646-B2 | Alkaloid aminoester derivatives and medicinal composition thereof | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-06-04 | — | — | US | claimed |
| US-20100173880-A1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2010-07-08 | — | — | US | claimed |
| EP-2376489-B1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF | CHIESI FARMA SPA (IT) | 2015-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173880-A1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF | CHRM3, CHRM1, CHRNG | CHRM2 4/4885CHRM3 1/4885CHRM1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.